Vitamin D Receptor Gene Polymorphisms Modify Cardiometabolic Response to Vitamin D Supplementation in T2DM Patients

Abstract There is conflicting evidence on the favorable effects of vitamin D supplementation on metabolic profile in Type 2 diabetes mellitus (T2DM) patients and this might be due to genetic variations in vitamin D receptors (VDRs). Thus, we studied the metabolic effects of a 12-month vitamin D supp...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Nasser M. Al-Daghri, Abdul Khader Mohammed, Omar S. Al-Attas, Mohammed Ghouse Ahmed Ansari, Kaiser Wani, Syed D. Hussain, Shaun Sabico, Gyanendra Tripathi, Majed S. Alokail
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/1e1419b590e743ef9b4a9852332ebf40
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1e1419b590e743ef9b4a9852332ebf40
record_format dspace
spelling oai:doaj.org-article:1e1419b590e743ef9b4a9852332ebf402021-12-02T12:32:12ZVitamin D Receptor Gene Polymorphisms Modify Cardiometabolic Response to Vitamin D Supplementation in T2DM Patients10.1038/s41598-017-08621-72045-2322https://doaj.org/article/1e1419b590e743ef9b4a9852332ebf402017-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-08621-7https://doaj.org/toc/2045-2322Abstract There is conflicting evidence on the favorable effects of vitamin D supplementation on metabolic profile in Type 2 diabetes mellitus (T2DM) patients and this might be due to genetic variations in vitamin D receptors (VDRs). Thus, we studied the metabolic effects of a 12-month vitamin D supplementation in T2DM patients according to VDR polymorphisms. A total of 204 T2DM subjects received 2000 IU vitamin D3 daily for 12 months. Serum 25(OH)D and metabolic profiles were measured at baseline and after 12 months. VDR polymorphisms (Taq-I, Bsm-I, Apa-I and Fok-I) were identified using TaqMan genotyping assays. Vitamin D supplementation significantly increased HOMA β-cell function (p = 0.003) as well as significantly decreased triglycerides, total and LDL-cholesterol (p < 0.001). The lowest increment in 25(OH)D levels was detected in patients with Fok-I CC genotypes (p < 0.0001). With vitamin D supplementation, Taq-I GG genotype carriers showed significant improvements in triglycerides, LDL- and total cholesterol, insulin, HbA1c and HOMA-IR (p < 0.005, 0.01, < 0.001, < 0.005, 0.03 and 0.01, respectively). Similarly, Bsm-I TT genotype carriers showed significant improvements in triglycerides (p = 0.01), insulin and HOMA-IR (p-values < 0.05). In conclusion, improvements in metabolic profile due to vitamin D supplementation is influenced by VDR polymorphisms, specifically for carriers of Taq-I GG and Bsm-I TT genotypes.Nasser M. Al-DaghriAbdul Khader MohammedOmar S. Al-AttasMohammed Ghouse Ahmed AnsariKaiser WaniSyed D. HussainShaun SabicoGyanendra TripathiMajed S. AlokailNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-10 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Nasser M. Al-Daghri
Abdul Khader Mohammed
Omar S. Al-Attas
Mohammed Ghouse Ahmed Ansari
Kaiser Wani
Syed D. Hussain
Shaun Sabico
Gyanendra Tripathi
Majed S. Alokail
Vitamin D Receptor Gene Polymorphisms Modify Cardiometabolic Response to Vitamin D Supplementation in T2DM Patients
description Abstract There is conflicting evidence on the favorable effects of vitamin D supplementation on metabolic profile in Type 2 diabetes mellitus (T2DM) patients and this might be due to genetic variations in vitamin D receptors (VDRs). Thus, we studied the metabolic effects of a 12-month vitamin D supplementation in T2DM patients according to VDR polymorphisms. A total of 204 T2DM subjects received 2000 IU vitamin D3 daily for 12 months. Serum 25(OH)D and metabolic profiles were measured at baseline and after 12 months. VDR polymorphisms (Taq-I, Bsm-I, Apa-I and Fok-I) were identified using TaqMan genotyping assays. Vitamin D supplementation significantly increased HOMA β-cell function (p = 0.003) as well as significantly decreased triglycerides, total and LDL-cholesterol (p < 0.001). The lowest increment in 25(OH)D levels was detected in patients with Fok-I CC genotypes (p < 0.0001). With vitamin D supplementation, Taq-I GG genotype carriers showed significant improvements in triglycerides, LDL- and total cholesterol, insulin, HbA1c and HOMA-IR (p < 0.005, 0.01, < 0.001, < 0.005, 0.03 and 0.01, respectively). Similarly, Bsm-I TT genotype carriers showed significant improvements in triglycerides (p = 0.01), insulin and HOMA-IR (p-values < 0.05). In conclusion, improvements in metabolic profile due to vitamin D supplementation is influenced by VDR polymorphisms, specifically for carriers of Taq-I GG and Bsm-I TT genotypes.
format article
author Nasser M. Al-Daghri
Abdul Khader Mohammed
Omar S. Al-Attas
Mohammed Ghouse Ahmed Ansari
Kaiser Wani
Syed D. Hussain
Shaun Sabico
Gyanendra Tripathi
Majed S. Alokail
author_facet Nasser M. Al-Daghri
Abdul Khader Mohammed
Omar S. Al-Attas
Mohammed Ghouse Ahmed Ansari
Kaiser Wani
Syed D. Hussain
Shaun Sabico
Gyanendra Tripathi
Majed S. Alokail
author_sort Nasser M. Al-Daghri
title Vitamin D Receptor Gene Polymorphisms Modify Cardiometabolic Response to Vitamin D Supplementation in T2DM Patients
title_short Vitamin D Receptor Gene Polymorphisms Modify Cardiometabolic Response to Vitamin D Supplementation in T2DM Patients
title_full Vitamin D Receptor Gene Polymorphisms Modify Cardiometabolic Response to Vitamin D Supplementation in T2DM Patients
title_fullStr Vitamin D Receptor Gene Polymorphisms Modify Cardiometabolic Response to Vitamin D Supplementation in T2DM Patients
title_full_unstemmed Vitamin D Receptor Gene Polymorphisms Modify Cardiometabolic Response to Vitamin D Supplementation in T2DM Patients
title_sort vitamin d receptor gene polymorphisms modify cardiometabolic response to vitamin d supplementation in t2dm patients
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/1e1419b590e743ef9b4a9852332ebf40
work_keys_str_mv AT nassermaldaghri vitamindreceptorgenepolymorphismsmodifycardiometabolicresponsetovitamindsupplementationint2dmpatients
AT abdulkhadermohammed vitamindreceptorgenepolymorphismsmodifycardiometabolicresponsetovitamindsupplementationint2dmpatients
AT omarsalattas vitamindreceptorgenepolymorphismsmodifycardiometabolicresponsetovitamindsupplementationint2dmpatients
AT mohammedghouseahmedansari vitamindreceptorgenepolymorphismsmodifycardiometabolicresponsetovitamindsupplementationint2dmpatients
AT kaiserwani vitamindreceptorgenepolymorphismsmodifycardiometabolicresponsetovitamindsupplementationint2dmpatients
AT syeddhussain vitamindreceptorgenepolymorphismsmodifycardiometabolicresponsetovitamindsupplementationint2dmpatients
AT shaunsabico vitamindreceptorgenepolymorphismsmodifycardiometabolicresponsetovitamindsupplementationint2dmpatients
AT gyanendratripathi vitamindreceptorgenepolymorphismsmodifycardiometabolicresponsetovitamindsupplementationint2dmpatients
AT majedsalokail vitamindreceptorgenepolymorphismsmodifycardiometabolicresponsetovitamindsupplementationint2dmpatients
_version_ 1718394145199882240